Table 1

Demographic and epidemiological characteristics of patients with COVID-19 with and without GI symptoms

CharacteristicGI symptoms (n=74)No GI symptoms (n=577)P value
Age46.14±14.1945.09±14.450.559
Sex (male)37/74 (50.0%)294/577 (50.95%)0.902
Current smoker3/74 (4.23%)38/577 (6.59%)0.610
Pre-existing conditions
 Any25/74 (33.78%)153/577 (26.52%)0.212
 Hypertension12/74 (16.22%)88/577 (15.25%)0.864
 Diabetes7/74 (9.46%)41/577 (7.11%)0.477
 Chronic liver disease8/74 (10.81%)17/577 (2.95%)0.004
 Cancer0/74 (0%)6/577 (1.04%)1.00
 Chronic renal disease0/74 (0%)6/577 (1.04%)1.00
 Heart disease1/74 (1.35%)4/577 (0.69%)0.454
 Pregnancy0/74 (0%)3/577 (0.52%)1.00
 COPD0/74 (0%)1/577 (0.17%)1.00
 Immunosuppression0/74 (0%)1/577 (0.17%)1.00
Exposure history
 From Wuhan38/74 (51.35%)347/577 (60.14%)0.167
 Contact with patients32/74 (43.24%)230/577 (39.86%)0.615
 Family cluster23/74 (31.08%)118/577 (20.45%)0.037
Clinical type on admission
Severe/Critical type (%)17/74 (22.97%)47/577 (8.14%)<0.001
  • Data are presented as medians (IQR), n (%) and n/N (%).

  • COPD, chronic obstructive pulmonary disease.